A BIT OF CALM PERSPECTIVE
Introduction by Caratacus
Here is another article from Russia Today.
It is somewhat irksome that we have to defer to Russian news sources for a rational and balanced view of things but such is the poor trustworthiness of British media we sometimes we need to.
Several important things emerge from this article and let’s summarise them here:
- It is not unusual for viruses to mutate. The COVID19 virus has already done it a couple of times.
- The normal pattern for viruses is that they mutate but the mutation is less severe than its predecessor.
- The influenza virus is a virus that mutates every year. When it mutates the vaccine that was developed for its predecessor does not work on the mutation so a new vaccine has to be developed and then a year later another vaccine has to be developed for the next strain.
- It seems likely that the Covid virus will follow the same pattern and there is every possibility – if it has not happened already – that the vaccines developed already and which have an as yet uncertain workability and safety will not work on the new strains.
We could therefore wind up in the position of having to develop a new vaccine every year and if the government vaccinates the entire population, everyone will receive a new vaccine every year. The health impact of a new vaccine being injected into you every year, year in and year out is unknown but likely to be considerable. No research has been done into the safety of multiple vaccines and what would be a safe number (one? ten? twelve? thirty?).
Bear in mind also that if one is going to vax annually against covid then logically one should also vax annually against flu which presents similar dangers and is in fact more dangerous to young age groups.
A far better, cheaper and safer approach would be to
- Pour coals on boosting the citizenry’s immune system with vits C, D, A and the mineral zinc so that the immune system is in better shape to defend the body. There is after all a known correlation between vitamin D deficiency and susceptibility to infection. There are of course other factors that weaken the immune system such as drugs (medicinal, psych, street), alcohol, heavy smoking and so forth that could be explored.
- Pour coals on the development of known cures such as hydroxychloroquine for those who do get a bad case of the bug. Hydroxy, so far as is known, will work on any mutation of the bug and indeed upon flu as well so far as I’m aware.
For those who want to take the risk (and they look at the moment to be considerable) with the rushed and inadequately trialed vaccines whose short medium and long term adverse reactions are not known, they should do so. The risk is theirs to take provided they are accurately informed as to the relative dangers of the bug versus the vaccine but they should bear in mind that the bug’s routine mutations may necessitate them being injected with a new vaccine every year.
Here is the article [SOURCE]
Contagious and mutated: What we know about the NEW coronavirus strain – and how much you need to worry
A new and more infectious strain of the Covid-19 coronavirus has spread to more countries around the globe. But what’s different about this new pathogen? And should people be prepping for a total apocalypse yet?
Ireland confirmed the presence of a new and highly infectious coronavirus strain on Friday, while authorities in Lebanon and Japan also recorded the first cases attributed to this variant. In continental Europe, Germany and Denmark confirmed the presence of the strain earlier this week, joining the Netherlands and Italy.
Little is yet known about the new strain – which bears the catchy name ‘SARS-CoV-2 VOC 202012/01.’ But while it certainly poses a problem, it does not appear as apocalyptic as some media have been presenting it.
Where did it come from?
The new strain is believed to have originated in the UK, and was first detected there in September. It spread rapidly, and testing data from UK laboratories show that in certain areas, it now accounts for more than two thirds of all cases of Covid-19.
The rapid spread of the new strain prompted British Prime Minister Boris Johnson to reimpose harsh restrictions on large swathes of the country, effectively cancelling Christmas for millions of Londoners and others in the southeast. More than 50 countries have banned travel to and from the UK, but with virologists predicting an upsurge of discoveries in new countries in the coming days, the EU has called on its members to lift their restrictions on UK travel.
What’s new about it?
The main factor setting the new strain apart from its predecessor is its infectiousness. Although pinning down exactly how much more transmissible is difficult, PM Johnson has repeatedly claimed the strain is 70 percent more infectious than the existing strain, apparently quoting physicians from Imperial College London and the government’s own New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG).
With the government floating such ominous figures, the media went into overdrive. The Sun described the new strain as a “nightmare before Christmas,” while Metro called it “Mutant Covid.” Even the more restrained Financial Times said that scientists are “alarmed” at the spread of the “Covid mutant.”
However, the evidence for increased transmissibility is still scant, and some dissenting doctors reckon there’s no proof of the new strain spreading faster at all. “We have not seen any evidence to back that claim up,” Professor of microbiology Hugh Pennington told the Scottish Sun this week. Others, including German virologist Christian Drosten, have said there is still not enough data to conclude whether the new strain is indeed more transmissible.
ALSO ON RT.COMTop German virologist casts doubt on fears of new ‘highly contagious’ UK Covid-19 strainSome specific claims about the new strain have also emerged, for instance that it transmits easier between children. Professor Neil Ferguson of NERVTAG made this claim earlier this week, but added that “more research would need to be done on the matter before any conclusions should be drawn.”
What threat does it pose?
On the surface, the idea of a mutated virus may spark alarm. However, the coronavirus variant prevalent before this new strain was itself a mutation of the original pathogen that emerged in Wuhan, China, a year ago. Upon reaching Europe in February the virus mutated into a strain known as ‘D614G,’ which then became the dominant strain worldwide. Another strain, A222V, broke out in Spain shortly afterwards and now accounts for up to seven percent of samples in Europe.
When ‘D614G’ emerged, scientists warned that it could be nine times as contagious as the Wuhan strain. Thankfully, this warning has never been proven to be the case.
All viruses mutate, usually becoming milder as they do. World Health Organization emergencies chief Mike Ryan told a virtual briefing this week that such mutations are “a normal part of virus evolution.”
At present there is no evidence that the new variant is any more deadly than the existing one. The UK, for example, reported just over 39,000 new cases of Covid-19 on Thursday, more than five times as many as on the worst day of the first wave in April. However, 574 deaths were recorded, around half as many as on several days in April.
Will vaccines protect against it?
At the moment, the consensus says yes. However, if the virus continues to mutate, there is a danger that it will learn how to evade the three vaccines currently available in the west. The influenza virus mutates so regularly that new flu vaccines are released every year to counter the virus’ latest adaptations.
So far, the coronavirus has not mutated rapidly enough to cause concerns about vaccine efficacy. Drugmakers Pfizer and Moderna are currently testing their vaccines against the new strain, while German firm BioNTech, which developed a vaccine along with Pfizer, said this week that a new formula could be whipped up in six weeks if necessary.
However, the virus could theoretically continue to mutate and stay one step ahead of vaccine developers. “This virus is potentially on a pathway for vaccine escape, it has taken the first couple of steps towards that,” Cambridge University professor Ravi Gupta told the BBC. “If we let it add more mutations, then you start worrying.”
Even with the threat of further mutations, though, scientists in the UK are trialling an experimental cocktail of antibodies that they say could stop anyone exposed to the coronavirus from going on to develop Covid-19.
Developed by University College London Hospitals and British-Swedish drug firm AstraZeneca, the treatment promises to confer instant immunity on anyone exposed to the pathogen.
Vaccines, on the other hand, can take up to a month to confer full immunity.
ALSO ON RT.COM